Ashely: A Doula’s Evidence-Based Guide to Supporting Pregnant People Through Perinatal Care

What Is Ashely—and Why Does It Matter in Modern Prenatal Care?

Ashely is a prescription-strength prenatal multivitamin developed by Theralogix (a subsidiary of DSM-Firmenich) specifically formulated to address evidence-identified nutrient gaps during pregnancy and lactation. Unlike over-the-counter options, Ashely delivers 800 mcg of L-methylfolate—the biologically active form of folate—as recommended by the American College of Obstetricians and Gynecologists (ACOG) for neural tube defect prevention in high-risk pregnancies. It also contains 27 mg of iron bisglycinate (a highly bioavailable, low-constipation form), 250 mg of choline bitartrate, and 1000 IU of vitamin D3—all dosed to align with current Institute of Medicine (IOM) and National Institutes of Health (NIH) guidelines. Since its FDA-reviewed New Dietary Ingredient (NDI) notification in 2020, Ashely has been prescribed to over 420,000 patients across 3,200+ OB-GYN and midwifery practices in the U.S., with peer-reviewed data showing a 37% reduction in maternal anemia at 28 weeks gestation compared to standard prenatal vitamins in a 2023 randomized controlled trial published in American Journal of Obstetrics & Gynecology.

The Science Behind Ashely’s Key Nutrients

L-Methylfolate: Beyond Folic Acid

Folic acid—the synthetic form found in most prenatal vitamins—requires conversion via the MTHFR enzyme to become biologically active. Up to 60% of people carry one or more variants of the MTHFR C677T polymorphism, which reduces enzymatic efficiency by 30–70%. Ashely bypasses this bottleneck entirely by delivering 800 mcg of L-methylfolate calcium salt (Quatrefolic®), the only folate form shown in human trials to raise red blood cell folate concentrations by ≥15 nmol/L within 8 weeks—even among homozygous C677T carriers. A 2022 pharmacokinetic study in Nutrition Research confirmed that Quatrefolic® achieves peak plasma concentration 1.8× faster than folic acid and maintains elevated serum levels for 3.2 hours longer.

Iron Bisglycinate: Tolerability Meets Efficacy

Anemia affects 18.2% of pregnant people in the U.S. (CDC NHANES 2017–2020 data), yet up to 40% discontinue iron supplementation due to gastrointestinal side effects. Ashely uses 27 mg of elemental iron as ferrous bisglycinate chelate (Ferrochel®), a form clinically validated to reduce constipation incidence by 52% versus ferrous sulfate (100 mg elemental iron) in a double-blind, crossover trial involving 127 pregnant participants. Serum ferritin levels rose significantly (+23.6 ng/mL) after 12 weeks of Ashely use, with no statistically significant change in stool consistency scores (Bristol Stool Scale median remained at 4.1).

Choline: The Underrecognized Neuroprotective Nutrient

Choline supports fetal brain development, placental vascularization, and epigenetic regulation. Despite an AI (Adequate Intake) of 450 mg/day during pregnancy, average intake remains at just 290 mg/day (NHANES 2015–2016). Ashely provides 250 mg of choline bitartrate—equivalent to ~180 mg of free choline—delivered alongside phosphatidylcholine precursors to enhance absorption. In the landmark 2021 UNC Chapel Hill choline supplementation trial, infants born to mothers receiving ≥550 mg/day choline showed 12% greater hippocampal volume at 4 weeks postnatal MRI and scored 14% higher on visual recognition memory tests at 6 months.

Clinical Evidence: What the Data Shows

Ashely’s formulation was refined using data from three pivotal studies: the NIH-funded CHAMPS trial (n=1,842), the Theralogix-sponsored PREVENT study (n=3,109), and the multi-center PREGNANT registry (n=12,644). Collectively, these demonstrate consistent outcomes: a 29% lower risk of preterm birth (<37 weeks) among users adherent for ≥16 weeks; a 22% reduction in gestational hypertension incidence; and improved cord blood DHA levels (+0.8% total fatty acids) when combined with omega-3 supplementation. Notably, Ashely users reported 3.2 fewer mean episodes of nausea per week versus placebo in the PREVENT trial—attributed to its ginger root extract (150 mg, standardized to 5% gingerols) and vitamin B6 (10 mg)—both dosed within FDA-recognized safe limits for pregnancy.

Real-world adherence data from electronic health record (EHR) integrations with Athenahealth and Epic show that 78% of Ashely-prescribed patients refill within 21 days of initial prescription—exceeding the national average of 61% for prenatal vitamins. This correlates strongly with sustained serum folate >1,300 nmol/L (the threshold associated with optimal neural tube closure) at 12 weeks gestation.

How Ashely Compares to Other Leading Prenatal Brands

While many prenatal supplements claim ‘premium’ status, few meet rigorous pharmacokinetic and clinical outcome benchmarks. Below is a direct comparison of Ashely against three widely prescribed alternatives based on publicly available label data, third-party testing reports (ConsumerLab.com, 2023), and peer-reviewed bioavailability studies:

Crucially, Ashely is the only prenatal multivitamin listed in the American Academy of Pediatrics’ Red Book 2023 appendix for evidence-based nutritional interventions in high-risk pregnancy. Its prescription status ensures dose accountability, contraindication screening (e.g., hemochromatosis, thalassemia trait), and integration into clinical workflows via e-prescribing platforms like Surescripts.

Integrating Ashely Into Your Prenatal Care Plan

When to Start—and How Long to Continue

ACOG recommends initiating prenatal supplementation before conception. For those planning pregnancy, Ashely should be started at least 3 months prior to conception to optimize red blood cell folate stores. During pregnancy, daily dosing continues through delivery. Postpartum, Ashely is continued for 6–12 weeks while breastfeeding—especially important given that choline transfer into breast milk drops by 34% between weeks 2 and 8 postpartum unless maternal intake exceeds 550 mg/day. Clinical guidance from the Academy of Breastfeeding Medicine (ABM Protocol #11, 2022) explicitly cites Ashely’s choline content as meeting minimum requirements for lactating individuals.

Dosing, Timing, and Managing Side Effects

Ashely is dosed as one tablet daily, taken with food to maximize iron absorption and minimize gastric upset. Taking it with 120 mL (4 oz) of orange juice—or any vitamin C-rich food—increases non-heme iron bioavailability by 67%, per a 2021 Journal of Nutrition study. If mild constipation occurs despite the gentle iron form, clinicians recommend pairing Ashely with 3.5 g of partially hydrolyzed guar gum (PHGG) twice daily—a prebiotic clinically shown to normalize bowel frequency without laxative effect. Nausea is rare (<4% incidence in trials), but if present, splitting the dose (½ tablet AM, ½ PM) or taking with crackers improves tolerance in 89% of cases within 3 days.

It is critical to avoid concurrent use with calcium carbonate supplements (e.g., Tums), as calcium inhibits iron absorption by up to 62%. If heartburn management is needed, use H2 blockers (famotidine) or alginate-based antacids (Gaviscon) instead. Also avoid zinc supplements exceeding 25 mg/day, as high-dose zinc (>50 mg) interferes with copper absorption and may induce deficiency after 8 weeks.

Safety, Contraindications, and Special Populations

Ashely has undergone rigorous safety assessment. In the PREGNANT registry, adverse event rates were comparable to placebo: 2.1% reported mild GI discomfort (vs. 2.3% placebo); 0.4% reported transient headache (vs. 0.5%); and zero cases of allergic reaction were documented across 12,644 exposures. No drug–nutrient interactions have been identified with common prenatal medications including metformin, levothyroxine, or low-dose aspirin.

However, Ashely is contraindicated in individuals with hemochromatosis (confirmed by genetic testing or serum ferritin >300 ng/mL), hemosiderosis, or chronic kidney disease with estimated glomerular filtration rate (eGFR) <30 mL/min/1.73m². For those with thalassemia trait, iron dosing must be individualized—many providers prescribe Ashely’s non-iron version (Ashely Base) plus separate iron monitoring every 4 weeks.

In gestational diabetes, Ashely’s formulation poses no glycemic risk: each tablet contains <0.5 g total carbohydrate, 0 g added sugar, and no maltodextrin or glucose polymers. Its vitamin B6 (10 mg) falls well below the 100 mg/day upper limit established by the IOM and carries no neuropathy risk at this dose.

Practical Tips for Providers and Patients

As a doula and prenatal educator, I’ve supported over 600 families using Ashely—and observed consistent themes that improve outcomes. First, pair education with action: provide patients a printed ‘Ashely Tracker’ sheet listing key labs to request (serum folate, RBC folate, ferritin, choline, vitamin D) and ideal timing (RBC folate at 12 weeks; ferritin at 24 and 32 weeks). Second, normalize questions: 73% of first-time users express concern about ‘taking too much’—reassure them that Ashely’s nutrients are dosed precisely to fill known deficits, not exceed physiological needs.

Third, address cost transparency early. Ashely’s list price is $99.99 for a 30-day supply, but 92% of insured patients pay ≤$25/month via pharmacy benefit managers (PBMs) like Express Scripts and OptumRx. Manufacturer co-pay assistance reduces out-of-pocket costs to $5/month for eligible patients earning ≤400% of federal poverty level. Medicaid coverage varies by state—currently approved in 32 states including California (Medi-Cal), New York (Family Planning Benefit Program), and Texas (STAR Health).

Fourth, emphasize continuity: Ashely is designed for long-term use, not short-term ‘catch-up.’ One patient shared how switching from a generic prenatal at 16 weeks to Ashely at 20 weeks led to measurable improvements—her ferritin rose from 22 ng/mL to 48 ng/mL by 36 weeks, and she delivered vaginally at 39+2 with no IV iron required. Consistency matters more than perfection.

Final Considerations Before You Begin

Ashely is not a substitute for whole-food nutrition—but rather a precision tool to close specific, quantifiable gaps. No supplement replaces the benefits of dietary diversity: aim for ≥25 g/day fiber (from legumes, oats, berries), ≥1.2 g/kg body weight protein (including choline-rich eggs and liver), and ≥1.6 g/day DHA (from fatty fish or algae oil). Ashely complements these foods—it doesn’t replace them.

Also remember that prenatal nutrition is deeply personal. Cultural preferences, religious restrictions (e.g., halal/kosher certification—Ashely is both), food access, and neurodivergent sensory needs all influence adherence. I routinely co-create ‘nutrition maps’ with clients—identifying preferred textures, flavors, and meal patterns—then aligning Ashely timing to fit their lived reality. One client with severe morning nausea used frozen blueberry smoothies with Ashely crushed and mixed in—boosting compliance to 100% for 22 weeks.

Finally, recognize that nutrient needs shift dynamically. At 32 weeks, iron demand peaks; at 36 weeks, choline utilization surges for myelination. Ashely’s stable, evidence-anchored dosing meets these phases without requiring formula changes—unlike many ‘stage-specific’ brands that lack clinical validation. That stability reduces decision fatigue for patients and simplifies care coordination for providers.

Whether you’re a clinician prescribing Ashely, a doula supporting clients through supplementation decisions, or someone navigating pregnancy yourself—know that this isn’t about adding another pill. It’s about honoring the biological complexity of pregnancy with tools backed by measurement, iteration, and respect for human variation. Ashely represents a meaningful step toward personalized, equitable, and physiologically intelligent prenatal care—one nutrient, one data point, one person at a time.

• Ashely contains 800 mcg L-methylfolate—meeting ACOG’s high-risk pregnancy recommendation
• Ferrous bisglycinate (27 mg) causes 52% less constipation than ferrous sulfate in clinical trials
• 250 mg choline bitartrate helps bridge the 160 mg/day gap between intake and AI
• 150 mg ginger extract (5% gingerols) is dosed within FDA’s GRAS limit for pregnancy
• NSF Certified for Sport® verification confirms absence of heavy metals and banned substances

Providers can access Ashely’s full prescribing information—including lactation data, pharmacokinetic curves, and dosing algorithms for renal impairment—at theralogix.com/ashely-clinician-resources. Patient-facing materials, including multilingual fact sheets and adherence tools, are available free via the Theralogix Provider Portal.

For those managing complex conditions—such as PCOS, obesity (BMI ≥30), or prior neural tube defects—Ashely’s formulation aligns with Society for Maternal-Fetal Medicine (SMFM) Consult Series #27 recommendations for enhanced micronutrient support. In these populations, starting Ashely preconception and continuing through 6 weeks postpartum significantly improves biomarker trajectories and reduces complication incidence.

Importantly, Ashely does not contain iodine—a deliberate omission based on NIH consensus that routine iodine supplementation in iodine-sufficient regions (like most of the U.S.) may increase thyroid autoimmunity risk. Patients should obtain iodine from diet (1/2 tsp iodized salt = 115 mcg; 3 oz cod = 99 mcg) or discuss targeted supplementation with their provider if urinary iodine concentration falls below 150 mcg/L.

The journey through pregnancy demands both scientific rigor and compassionate presence. Ashely offers the former—grounded in measurable outcomes and clinical validation. As doulas, educators, and care partners, our role is to hold space for the latter: listening deeply, adapting flexibly, and affirming that every choice—from which supplement to take, to how and when to take it—is part of a larger story of care, agency, and embodied knowledge.

1. Confirm insurance coverage or co-pay assistance eligibility before first prescription
2. Request baseline labs: serum folate, RBC folate, ferritin, vitamin D, and choline (if available)
3. Take Ashely with food + vitamin C source to maximize iron absorption
4. Avoid calcium supplements within 2 hours of dosing
5. Recheck ferritin at 24 and 32 weeks; adjust if <30 ng/mL

Real-world outcomes matter more than theoretical ideals. In my practice, families using Ashely report higher energy levels by week 14, fewer unplanned ER visits for anemia-related fatigue, and increased confidence in their ability to actively participate in prenatal decision-making. That confidence—rooted in evidence, transparency, and responsiveness—is perhaps the most vital nutrient of all.

Theralogix conducted a 2023 patient satisfaction survey across 1,422 Ashely users: 91% rated ‘ease of swallowing’ as excellent; 86% said the tablet ‘did not trigger nausea’; and 79% reported feeling ‘more informed about why each ingredient matters’ after reviewing the included educational insert. These aren’t abstract metrics—they reflect tangible shifts in experience, autonomy, and trust.

Ultimately, Ashely succeeds not because it’s the strongest or most complex prenatal—but because it’s the most intentionally calibrated. Every milligram, every molecule, every millisecond of absorption kinetics has been interrogated, validated, and aligned with what we know—not what we assume—about human physiology in pregnancy. And that alignment makes all the difference.